- Home
- PLUR vs ATRA Comparison
PLUR vs ATRA Comparison
Compare PLUR & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- ATRA
- Stock Information
- Founded
- PLUR 2001
- ATRA 2012
- Country
- PLUR Israel
- ATRA United States
- Employees
- PLUR N/A
- ATRA N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLUR Health Care
- ATRA Health Care
- Exchange
- PLUR Nasdaq
- ATRA Nasdaq
- Market Cap
- PLUR 41.9M
- ATRA 40.1M
- IPO Year
- PLUR N/A
- ATRA 2014
- Fundamental
- Price
- PLUR $5.88
- ATRA $8.68
- Analyst Decision
- PLUR Strong Buy
- ATRA Buy
- Analyst Count
- PLUR 1
- ATRA 5
- Target Price
- PLUR $12.00
- ATRA $17.75
- AVG Volume (30 Days)
- PLUR 62.9K
- ATRA 41.2K
- Earning Date
- PLUR 05-13-2025
- ATRA 08-11-2025
- Dividend Yield
- PLUR N/A
- ATRA N/A
- EPS Growth
- PLUR N/A
- ATRA N/A
- EPS
- PLUR N/A
- ATRA N/A
- Revenue
- PLUR $1,034,000.00
- ATRA $199,732,000.00
- Revenue This Year
- PLUR $472.39
- ATRA N/A
- Revenue Next Year
- PLUR $254.29
- ATRA N/A
- P/E Ratio
- PLUR N/A
- ATRA N/A
- Revenue Growth
- PLUR 203.23
- ATRA 475.53
- 52 Week Low
- PLUR $3.33
- ATRA $5.01
- 52 Week High
- PLUR $7.13
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- PLUR 66.26
- ATRA 57.82
- Support Level
- PLUR $4.61
- ATRA $7.54
- Resistance Level
- PLUR $5.40
- ATRA $8.25
- Average True Range (ATR)
- PLUR 0.55
- ATRA 0.48
- MACD
- PLUR 0.13
- ATRA -0.04
- Stochastic Oscillator
- PLUR 91.46
- ATRA 64.09
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).